![PRD_001082 PRD_001082](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001082.svg) | PRD_001082 | Name: | Tripeptide fluoromethyl ketone inhibitor Z-VAE(OMe)-FMK | Formula: | C23 H32 F N3 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001088 PRD_001088](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001088.svg) | PRD_001088 | Name: | D-peptide inhibitor | Formula: | C75 H106 N17 O17 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001091 PRD_001091](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001091.svg) | PRD_001091 | Name: | monomeric peptide inhibitor | Formula: | C72 H103 N19 O16 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001092 PRD_001092](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001092.svg) | PRD_001092 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-cysteinamide | Formula: | C23 H37 N8 O4 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001093 PRD_001093](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001093.svg) | PRD_001093 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-isoleucinamide | Formula: | C26 H43 N8 O4 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001098 PRD_001098](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001098.svg) | PRD_001098 | Name: | TMC-95A mimic ligand 2b | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001103 PRD_001103](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001103.svg) | PRD_001103 | Name: | TMC-95A mimic ligand 2a | Formula: | C42 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001105 PRD_001105](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001105.svg) | PRD_001105 | Name: | TMC-95A mimic ligand 2c | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001109 PRD_001109](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001109.svg) | PRD_001109 | Name: | peptide ligand | Formula: | C35 H51 Cl N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001111 PRD_001111](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001111.svg) | PRD_001111 | Name: | peptide ligand | Formula: | C35 H50 Cl2 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001117 PRD_001117](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001117.svg) | PRD_001117 | Name: | Peptide aldehyde inhibitor Ac-NSFSQ-H | Formula: | C26 H39 N7 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001118 PRD_001118](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001118.svg) | PRD_001118 | Name: | Peptide aldehyde inhibitor Ac-DSFDQ-H | Formula: | C27 H38 N6 O12 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000771 PRD_000771](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000771.svg) | PRD_000771 | Name: | Peptide aldehyde inhibitor Ac-NSTSQ-H | Formula: | C21 H37 N7 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000772 PRD_000772](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000772.svg) | PRD_000772 | Name: | Peptide aldehyde inhibitor Ac-ESTLQ-H | Formula: | C25 H44 N6 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000776 PRD_000776](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000776.svg) | PRD_000776 | Name: | Lyngbyastatin 7 | Formula: | C48 H66 N8 O12 | Definition date: | 2013-02-06 | Last modified: | 2013-06-03 |
|
![PRD_000780 PRD_000780](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000780.svg) | PRD_000780 | Name: | PL-49 | Formula: | C36 H63 N9 O11 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
![PRD_000786 PRD_000786](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000786.svg) | PRD_000786 | Name: | Peptide inhibitor (ACE)VDV(3PX)D-CHO | Formula: | C28 H47 N5 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000793 PRD_000793](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000793.svg) | PRD_000793 | Name: | ACE-AEIK-CHO ALDEHYDE peptide inhibitor | Formula: | C22 H41 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000794 PRD_000794](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000794.svg) | PRD_000794 | Name: | C6H5(CH2)8-derivatized peptide inhibitor | Formula: | C40 H63 N8 O11 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000807 PRD_000807](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000807.svg) | PRD_000807 | Name: | hydrocinnamoyl-derivatized PLHSpTA peptide | Formula: | C36 H55 N9 O12 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000808 PRD_000808](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000808.svg) | PRD_000808 | Name: | D-peptide inhibitor | Formula: | C70 H110 N19 O19 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000809 PRD_000809](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000809.svg) | PRD_000809 | Name: | LDPPLHSpTA phosphopeptide | Formula: | C44 H72 N12 O17 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000810 PRD_000810](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000810.svg) | PRD_000810 | Name: | 3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide | Formula: | C47 H67 N11 O16 P S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000816 PRD_000816](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000816.svg) | PRD_000816 | Name: | DIMERIC PEPTIDE INHIBITOR | Formula: | C78 H116 N21 O17 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000854 PRD_000854](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000854.svg) | PRD_000854 | Name: | DB6 peptide | Formula: | C57 H77 N13 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|